Skip to main content

Advertisement

Log in

Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 27 March 2024

Abstract

Purpose

This study investigates the utility of ureteroscopic surgery (URS) as an alternative to radical nephroureterectomy (RNU) in managing upper tract urothelial carcinoma (UTUC), with a focus on survival outcomes and re-evaluation of current the European Association of Urology guidelines criteria.

Methods

We conducted a retrospective, multi-institutional review of 143 UTUC patients treated with URS (n = 35) or RNU (n = 108). Clinicopathological factors were analyzed, and survival outcomes were assessed using Kaplan–Meier analysis and Cox proportional-hazards models.

Results

The median follow-up period was 27 months. Overall survival (OS) and radiographic progression-free survival (rPFS) were comparable between the URS and RNU groups (OS: HR 2.42, 95% CI 0.63–9.28, P = 0.0579; rPFS: HR 1.82, 95% CI 0.60–5.47, P = 0.1641). URS conferred superior renal function preservation. In patients characterized by factors such as radiographically invisible lesions, negative cytology, pTa stage, low-grade tumors, and multiple lesions, the OS outcomes with URS were comparable to those with RNU as follows: radiographically invisible lesions (P = 0.5768), negative cytology (P = 0.7626), pTa stage (P = 0.6694), low-grade tumors (P = 0.9870), and multiple lesions (P = 0.8586).

Conclusion

URS offers survival outcomes similar to RNU, along with better renal function preservation, especially in low-risk UTUC patients. These findings underscore the urgency of re-evaluating the current EAU guidelines and encourage further research into determining the ideal patient selection for URS in UTUC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

No datasets were generated or analyzed during the current study.

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33

    Article  PubMed  Google Scholar 

  2. Roupret M, Seisen T, Birtle AJ, Capoun O, Comperat EM, Dominguez-Escrig JL et al (2023) European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84:49–64

    Article  PubMed  Google Scholar 

  3. Bin X, Roy OP, Ghiraldi E, Manglik N, Liang T, Vira M et al (2012) Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours. BJU Int 110:E514–E519

    Article  PubMed  Google Scholar 

  4. Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110:1618–1626

    Article  PubMed  Google Scholar 

  5. Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M et al (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol 70:1052–1068

    Article  PubMed  Google Scholar 

  6. Kawada T, Laukhtina E, Quhal F, Yanagisawa T, Rajwa P, Pallauf M et al (2023) Oncologic and safety outcomes for endoscopic surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: an updated systematic review and meta-analysis. Eur Urol Focus 9:236–240

    Article  PubMed  Google Scholar 

  7. Matsunaga T, Komura K, Hashimoto T, Muraoka R, Satake N, Tsutsumi T et al (2020) Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort. World J Urol 38:3183–3190

    Article  CAS  PubMed  Google Scholar 

  8. Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu JN et al (2016) Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34:1201–1206

    Article  PubMed  Google Scholar 

  9. Hoffman A, Yossepowitch O, Erlich Y, Holland R, Lifshitz D (2014) Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy—a case control study. BMC Urol 14:97

    Article  PubMed  PubMed Central  Google Scholar 

  10. Leppert JT, Lamberts RW, Thomas IC, Chung BI, Sonn GA, Skinner EC et al (2018) Incident CKD after radical or partial nephrectomy. J Am Soc Nephrol 29:207–216

    Article  PubMed  Google Scholar 

  11. Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT et al (2014) Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int 114:216–220

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chen YT, Yu CC, Yeh HC, Lee HY, Jiang YH, Lee YK et al (2021) Endoscopic management versus radical nephroureterectomy for localized upper tract urothelial carcinoma in a high endemic region. Sci Rep 11:4040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was partially supported by the Grant-in-Aid No. 22K20806 (Japan Society for the Promotion of Science: JSPS)

Author information

Authors and Affiliations

Authors

Contributions

TT: data collection and management, data analysis, Manuscript writing; KK: data management, Data analysis, project development; TI: data collection and management, project development; RM: data collection and management, data analysis; TH: data collection and management, project development; TA: data collection; YH: data collection; ST: data collection; TO: data collection; SY: data collection; TF: Data collection; KN: data collection; YY: data collection; KN: data collection. SK: data collection; KN: data collection; TT: data collection; TM: data collection; YY: data collection; TU: data collection; TT: data collection; KM: data collection; HU: data analysis; HH: data analysis; HN: data analysis; KT: Manuscript editing; YO: manuscript editing; HA: project development, manuscript editing.

Corresponding author

Correspondence to Takuya Tsujino.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This retrospective study involving human participants was approved by the institutional review board of Osaka Medical and Pharmaceutical University (IRB approval number: RIN-750-2571, date of approval: 24 January 2020) and conducted in accordance with the World Medical Association Declaration of Helsinki.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 7656 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsujino, T., Komura, K., Inamoto, T. et al. Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma. World J Urol 41, 3585–3591 (2023). https://doi.org/10.1007/s00345-023-04687-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-023-04687-3

Keywords

Navigation